These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 1968750)

  • 1. Dominant oncogenes and tumor suppressor genes in the pathogenesis of lung cancer.
    Viallet J; Minna JD
    Am J Respir Cell Mol Biol; 1990 Mar; 2(3):225-32. PubMed ID: 1968750
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The evidence for human tumor suppressor genes.
    Stanbridge EJ
    Princess Takamatsu Symp; 1989; 20():3-13. PubMed ID: 2577336
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The involvement of oncogenes and suppressor genes in human neoplasia.
    Brodeur GM
    Adv Pediatr; 1987; 34():1-44. PubMed ID: 3318293
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic changes in the pathogenesis of lung cancer.
    Birrer MJ; Minna JD
    Annu Rev Med; 1989; 40():305-17. PubMed ID: 2658754
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Lung cancer, smoking and genetic modifications].
    Popescu I
    Pneumologia; 2008; 57(1):25-8. PubMed ID: 18543657
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inactivation of the retinoblastoma susceptibility gene in non-small-cell lung cancer. The Lung Cancer Study Group.
    Reissmann PT; Koga H; Takahashi R; Figlin RA; Holmes EC; Piantadosi S; Cordon-Cardo C; Slamon DJ
    Oncogene; 1993 Jul; 8(7):1913-9. PubMed ID: 8390038
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The molecular genetics of lung cancer.
    Carbone DP; Minna JD
    Adv Intern Med; 1992; 37():153-71. PubMed ID: 1348393
    [No Abstract]   [Full Text] [Related]  

  • 8. Molecular genetics of small cell lung carcinoma.
    Wistuba II; Gazdar AF; Minna JD
    Semin Oncol; 2001 Apr; 28(2 Suppl 4):3-13. PubMed ID: 11479891
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [2000 Standards, Options and Recommendations for prognostic value of oncogenes and tumor suppressor genes in non small cell lung cancer].
    Bréchot JM; Molina T; Theobald S; Depierre A; Lagrange JL; Astoul P; Baldeyrou P; Bardet E; Bazelly B; Breton JL; Douillard JY; Grivaux M; Jacoulet P; Khalil A; Lemarié E; Martinet Y; Massard G; Milleron B; Moro-Sibilot D; Paesmans M; Pujol JL; Quoix AE; Ranfaing E; Rivière A; Sancho-Garnier H; Souquet PJ; Spaeth D; Stcebner-Delbarre A;
    Bull Cancer; 2002 Oct; 89(10):857-67. PubMed ID: 12441277
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of oncogenes and tumour suppressor genes in human lung carcinogenesis.
    Harris CC; Reddel R; Pfeifer A; Iman D; McMenamin M; Trump BF; Weston A
    IARC Sci Publ; 1991; (105):294-304. PubMed ID: 1855868
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic alterations in mouse lung tumors: implications for cancer chemoprevention.
    Herzog CR; Lubet RA; You M
    J Cell Biochem Suppl; 1997; 28-29():49-63. PubMed ID: 9589349
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Molecular approach to lung cancer].
    Takahashi T; Ueda R; Takahashi T
    Nihon Kyobu Shikkan Gakkai Zasshi; 1995 Dec; 33 Suppl():29-32. PubMed ID: 8752479
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nakahara memorial lecture. Hereditary cancer, oncogenes, and anti-oncogenes.
    Knudson AG
    Princess Takamatsu Symp; 1989; 20():15-29. PubMed ID: 2577335
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic alterations of multiple tumor suppressors and oncogenes in the carcinogenesis and progression of lung cancer.
    Osada H; Takahashi T
    Oncogene; 2002 Oct; 21(48):7421-34. PubMed ID: 12379883
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The relationship between oncogenes and chromosome abnormalities in the pathogenesis and progression of lung cancer].
    Yokota J; Wada M; Sugimura T; Terada M
    Gan No Rinsho; 1989 May; Spec No():157-63. PubMed ID: 2689660
    [No Abstract]   [Full Text] [Related]  

  • 16. Genetics of human cancer.
    Knudson AG
    Annu Rev Genet; 1986; 20():231-51. PubMed ID: 2880556
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chromosomal deletion, gene amplification, alternative processing, and autocrine growth factor production in the pathogenesis of human lung cancer.
    Minna JD; Battey JF; Birrer M; Brooks BJ; Cuttitta F; DeGreve J; Gazdar AF; Johnson BE; Nau MM; Sausville EA
    Princess Takamatsu Symp; 1986; 17():109-22. PubMed ID: 3332004
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A tumor suppressor gene on chromosome 1p32-pter controls the amplification of MYC family genes in breast cancer.
    Bièche I; Champème MH; Lidereau R
    Cancer Res; 1994 Aug; 54(16):4274-6. PubMed ID: 7913873
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Genetic abnormalities in lung cancer and their prognostic implications].
    Mitsudomi T; Takahashi T
    Gan To Kagaku Ryoho; 1996 Jul; 23(8):990-6. PubMed ID: 8687234
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Tumor suppressor genes. New perspectives for clinical investigations in cancer].
    Paván J; Gualandi F; Rimessi P; Corallini A; Barbanti-Brodano G
    Medicina (B Aires); 1994; 54(2):163-8. PubMed ID: 7997135
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.